Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Liabilities ₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹14,925 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr
Mar2021₹14,069 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr
9.44
Mar2021 ₹14,069 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,201.7 Cr -0.5% 5.3% 43.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹98,795.9 Cr -1.1% -6.3% -18.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.5%

5.3%

43.5%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses